SNDL
Sndl Inc
NASDAQ · Pharmaceuticals
$1.51
+0.06 (+4.14%)
Open$1.46
Previous Close$1.45
Day High$1.52
Day Low$1.45
52W High$2.89
52W Low$1.15
Volume—
Avg Volume1.44M
Market Cap388.83M
P/E Ratio—
EPS$-0.35
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+969.5% upside
Current
$1.51
$1.51
Target
$16.15
$16.15
$10.52
$16.15 avg
$19.28
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 897.13M | 64.47M | 59.12M |
| Net Income | -92,391,000 | 22.72M | 16.50M |
| Profit Margin | -10.3% | 35.2% | 27.9% |
| EBITDA | 2.21M | 29.98M | 25.74M |
| Free Cash Flow | — | 15.79M | 14.78M |
| Rev Growth | +154.1% | +0.6% | +13.8% |
| Debt/Equity | 0.13 | 0.27 | 0.23 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |